From the Departments of Anesthesia and Perioperative Care (M.B., E.N.Y., K.K., S.K., M.W.H., P.A.) Orthopedic Surgery (A.L.Z.) University of California at San Francisco, San Francisco, California.
Anesthesiology. 2018 Sep;129(3):536-543. doi: 10.1097/ALN.0000000000002321.
WHAT THIS ARTICLE TELLS US THAT IS NEW: BACKGROUND:: Ambulatory hip arthroscopy is associated with postoperative pain routinely requiring opioid analgesia. The potential role of peripheral nerve blocks for pain control after hip arthroscopy is controversial. This trial investigated whether a preoperative fascia iliaca block improves postoperative analgesia.
In a prospective, double-blinded trial, 80 patients scheduled for hip arthroscopy were randomized to receive a preoperative fascia iliaca block with 40 ml ropivacaine 0.2% or saline. Patients also received an intraarticular injection of 10-ml ropivacaine 0.2% at procedure end. Primary study endpoint was highest pain score reported in the recovery room; other study endpoints were pain scores and opioid use 24 h after surgery. Additionally, quadriceps strength was measured to identify leg weakness.
The analysis included 78 patients. Highest pain scores in the recovery room were similar in the block group (6 ± 2) versus placebo group (7 ± 2), difference: -0.2 (95% CI, -1.1 to 0.7), as was opioid use (intravenous morphine equivalent dose: 15 ± 7mg [block] vs. 16 ± 9 mg [placebo]). Once discharged home, patients experienced similar pain and opioid use (13 ± 7 mg [block] vs. 12 ± 8 mg [placebo]) in the 24 h after surgery. The fascia iliaca block resulted in noticeable quadriceps weakness. There were four postoperative falls in the block group versus one fall in the placebo group.
Preoperative fascia iliaca blockade in addition to intraarticular local anesthetic injection did not improve pain control after hip arthroscopy but did result in quadriceps weakness, which may contribute to an increased fall risk. Routine use of this block cannot be recommended in this patient population.
这篇文章告诉我们新的内容:背景:门诊髋关节镜检查术后常需阿片类镇痛药缓解疼痛。髋关节镜术后应用外周神经阻滞控制疼痛的作用存在争议。本试验旨在研究髋关节镜术前股外侧肌筋膜间隙阻滞是否能改善术后镇痛效果。
前瞻性、双盲试验中,80 例行髋关节镜手术的患者随机分为接受 40ml 0.2%罗哌卡因行股外侧肌筋膜间隙阻滞或生理盐水的股外侧肌筋膜间隙阻滞组。患者在手术结束时还接受关节内注射 10ml 0.2%罗哌卡因。主要研究终点为恢复室中报告的最高疼痛评分;其他研究终点为术后 24 小时的疼痛评分和阿片类药物使用情况。此外,还测量股四头肌力量以确定腿部无力。
分析纳入 78 例患者。阻滞组(6 ± 2)与安慰剂组(7 ± 2)在恢复室的最高疼痛评分相似,差异为-0.2(95%CI,-1.1 至 0.7),阿片类药物使用量(静脉注射吗啡等效剂量:15 ± 7mg[阻滞组]与 16 ± 9mg[安慰剂组])也相似。一旦出院回家,术后 24 小时内,患者经历的疼痛和阿片类药物使用量相似(13 ± 7mg[阻滞组]与 12 ± 8mg[安慰剂组])。股外侧肌筋膜间隙阻滞导致明显的股四头肌无力。阻滞组有 4 例术后跌倒,安慰剂组有 1 例跌倒。
髋关节镜术后除关节内局部麻醉注射外,行股外侧肌筋膜间隙阻滞不能改善疼痛控制,但会导致股四头肌无力,可能增加跌倒风险。在该患者人群中,不能常规推荐使用这种阻滞。